The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Imidaflea 40 mg Spot-on solution for Small Cats, Small Pet Rabbits & Small Dogs

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/139/001

Main Information

Trade NameImidaflea 40 mg Spot-on solution for Small Cats, Small Pet Rabbits & Small Dogs
Active SubstancesImidacloprid
Dosage FormSpot-on solution
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
License Holder AddressIda Industrial Estate
Dublin Road
Co. Galway
Licence NumberVPA10987/139/001

Group Information

ATC CodeQP53AX17 imidacloprid
Therapeutic ClassEctoparasiticide


License statusAuthorised
Licence Issued25/10/2019
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back